Payback -polluting tools for artificial intelligence developed by a researcher at a Scottish university will revolutionize the diagnosis of skin cancer and offer fast and potentially life -saving reviews in the regions of the world away worldwide.
Tess Watt, doctoral student at Heriot-Watt University in Edinburgh, directed the project and introduced himself to a future in which early detection of skin diseases is accessible worldwide without direct access to dermatologists or internet.
The system includes a patient who takes up a photo of his skin complaint using a small camera that is attached to a raspberry Pi device-an inexpensive, energy-efficient handheld computer.
This device stores an enormous data record of thousands of images, against which the photo is analyzed in real time using the educational classification on the latest cartels in order to achieve a diagnosis.
These results are then promptly shared to a local GP service that enables the initiation of a suitable treatment plan.
The project is considered the first of its kind of AI Medical Diagnosis with the aim of serving remote communities.
Doctoral student Tess Watt has developed AI tools that enable people in remote areas of the world to fast and possibly life-saving skin cancer diagnoses (Heriot-Watt University/PA Wire)
Ms. Watt said: “The healthcare system from home is currently a really important topic, especially since the waiting times of the GP continue to grow.
“If we can empower humans to monitor the skin diseases from their own houses with AI, we can drastically reduce delays in diagnosis.”
A prototype of the device has already been demonstrated in the Advanced Health and Care Technologies Suite from Heriot-Watt.
The research team said that the tool had up to 85 percent in its diagnostic functions. However, they hope to further increase this by gaining access to more skin lesion data sets that are supported by advanced machine tools.
Ms. Watt is also in conversations with NHS Scotland to begin the ethical approval process for the examination of the technology in clinical environments in the real world.
“Hopefully we will have a pilot project ongoing in the next few years or two,” she said, noticing that medical technology often takes years to convert the prototype to implement it.
She added: “When I end my doctorate in three years, I would like to look a little in the pipeline that is on the way to the use of real world.”
The university said that the long -term vision is to roll out the system in remote regions of Scotland before it starts in global areas with limited access to dermatological care.
It also added that the technology also for patients who are more frequent or not able to offer important support to support relatives to record and transmit diagnostic images to GPS.
Ms. Watt’s academic supervisor, Dr. Christos Chrysoulas, said: “E-Health devices must be constructed in such a way that they work independently of external connectivity to ensure the continuity of the patient service and security.
“In the case of a network or cloud service error, such devices must fail and maintain all essential clinical operations without functional dismantling.
“While auxiliary or non-critical characteristics cannot be temporarily available, the diagnostic and even core therapeutic functions must remain in accordance with the safety and regulatory requirements.
“The nature of our research, especially for use in resource -limited environments and areas with limited or without connectivity in which uninterrupted patient care can still be guaranteed, is the guarantee of this resilience in affordable, inexpensive medical devices.”